Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Guidance on Anti-Infective Non-Inferiority Margins May Not Be Clear-Cut

Nov 17 2008

• By Lauren Smith

Related Content

Antibiotic Non-Inferiority Trials To Be Addressed By FDA Advisory Committee

Oct 20 2008

Theravance’s Telavancin Data Integrity Issues Resolved; FDA Review Back On Track

Oct 16 2008

FDA Still Needs Convincing On Use Of Non-Inferiority Trials For CAP – Temple

Feb 04 2008

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window